SUPN - Supernus Pharma appoints Opgen executive as new CFO

Supernus Pharmaceuticals (SUPN -5.0%) is trading lower in morning hours after the company announced the resignation of its chief financial officer, James P. Kelly, effective August 13. On July 27, the company has appointed Timothy C. Dec as its new senior vice-president and CFO with effect from August 23. Mr. Kelly who is also the executive vice-president has notified on July 23 that he will be leaving the company to join another firm, Supernus said in a regulatory filing on Thursday after the market close. With 35 years of industry experience, Mr. Dec joins Supernus following a stint at OpGen, where he served as CFO from April 2015 – July 2021. Meanwhile, announcing Dec’s resignation, OpGen (OPGN -7.1%) said that the company has begun an executive search process to find his replacement ahead of his departure on August 20.

For further details see:

Supernus Pharma appoints Opgen executive as new CFO